One of the risks of any large operation is the occurrence of blood clots. To prevent this, patients are routinely given the anticoagulant heparin or related drugs. American scientists have now introduced a new approach to the production of synthetic heparin mimetics with better activity profiles.
Heparin has been used as an anticoagulant since 1935 to both treat and prevent the deep vein thrombosis that can result from operations, blood transfusions, or dialysis. Heparin is a substance produced by the body and consists of long chains of sugar (saccharide) molecules. The sugar building blocks contain a large number of sulfate groups.
Because heparin is obtained from animal tissues, its use does pose some problems. Contamination may lead to health risks. Furthermore, batches of the drug are often not homogeneous so the effectiveness of a given dose must be calculated case by case. In about 3 % of patients, long-term treatment with heparin leads to a dangerous autoimmune disease.
Low-molecular-weight drugs such as Arixtra, which contains only five sugar groups, have been developed as an alternative. Their disadvantage is the very complex and expensive process used to make them.
Linda C. Hsieh-Wilson and her team at the California Institute of Technology in Pasadena have now uncovered an interesting new angle: synthetic glycopolymers, long chains of molecules that have sugar molecules as side groups. The researchers chose to use two sugars typically found in heparin as side groups.
One of these sugars was equipped with an additional sulfate group. The synthesis of such glycopolymers is much simpler than the synthesis of natural polysaccharides, but it is still a complex undertaking, and it is made more difficult in this case because of the need to attach sulfate groups in a controlled fashion. The team was able to use a ring-opening metathesis polymerization reaction (ROMP) to make polymer chains of varying length with a maximum of 45 units.
The longer molecular chains demonstrate stronger activity than anticoagulants currently in clinical use. The additional sulfate group is critical to this effectiveness. Interestingly, systematic changes to the length of the chain and pattern of sulfate groups allow for fine-tuning of the anticoagulant effect. This makes it possible to make drugs with different activities from those previously in clinical use. For example, the glycopolymer containing 45 building blocks targeted the two major branches of the blood coagulation cascade to a different extent than both the small molecule and heparin polysaccharide drugs.About the Author
Linda C. Hsieh-Wilson | Angewandte Chemie
Megakaryocytes act as „bouncers“ restraining cell migration in the bone marrow
16.07.2019 | Rudolf-Virchow-Zentrum für Experimentelle Biomedizin der Universität Würzburg
A human liver cell atlas
15.07.2019 | Max Planck Institute of Immunobiology and Epigenetics
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.
Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...
The fly agaric with its red hat is perhaps the most evocative of the diverse and variously colored mushroom species. Hitherto, the purpose of these colors was...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
16.07.2019 | Physics and Astronomy
16.07.2019 | Power and Electrical Engineering
16.07.2019 | Information Technology